Mark J. Alexander

1.4k total citations · 1 hit paper
17 papers, 1.0k citations indexed

About

Mark J. Alexander is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Mark J. Alexander has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 7 papers in Reproductive Medicine. Recurrent topics in Mark J. Alexander's work include Neuropeptides and Animal Physiology (8 papers), Hypothalamic control of reproductive hormones (7 papers) and Receptor Mechanisms and Signaling (4 papers). Mark J. Alexander is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Hypothalamic control of reproductive hormones (7 papers) and Receptor Mechanisms and Signaling (4 papers). Mark J. Alexander collaborates with scholars based in United States, Switzerland and Greece. Mark J. Alexander's co-authors include Susan E. Leeman, William Rostène, Ravindra Kumar, Rajasekhar N.V.S. Suragani, R. Scott Pearsall, Sharon M Cawley, Robert Li, Asya V. Grinberg, Dianne Sako and Monique V. Davies and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Mark J. Alexander

17 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis

2014 346 citations Rajasekhar N.V.S. Suragani, Samuel M. Cadena et al. Nature Medicine profile →

Peers

Countries citing papers authored by Mark J. Alexander

Since Specialization

Citations

This map shows the geographic impact of Mark J. Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Alexander more than expected).

Fields of papers citing papers by Mark J. Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Alexander. The network helps show where Mark J. Alexander may publish in the future.

Co-authorship network of co-authors of Mark J. Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Alexander. A scholar is included among the top collaborators of Mark J. Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Alexander. Mark J. Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure 2023 ·Frontiers in Cardiovascular Medicine ·Sachindra Raj Joshi, (unknown), Jun Liu, Yan Ding, Steven D. Briscoe, Mark J. Alexander, Patrick André, Ravindra Kumar, (unknown)	13
2	Therapeutic Approaches for Treating Pulmonary Arterial Hypertension by Correcting Imbalanced TGF-β Superfamily Signaling 2022 ·Frontiers in Medicine ·Patrick André, Sachindra Raj Joshi, Steven D. Briscoe, Mark J. Alexander, Gang� Li, Ravindra Kumar	32
3	Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes 2020 ·Journal of Clinical Investigation ·Amit Verma, Rajasekhar N.V.S. Suragani, Srinivas Aluri, Nishi Shah, Tushar D. Bhagat, Mark J. Alexander, Rami S. Komrokji, Ravi Kumar	45
4	Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Roselyne Castonguay, Jennifer Lachey, (unknown), (unknown), Katia Liharska, (unknown), (unknown), Monique V. Davies, Dianne Sako, (unknown), Lavanya Krishnan, Aaron W. Mulivor, Huiming Li, Sarah Keates, Mark J. Alexander, R. Scott Pearsall, Ravi Kumar	20
5	Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia 2014 ·Blood ·Rajasekhar N.V.S. Suragani, Sharon M Cawley, Robert Li, (unknown), Mark J. Alexander, Aaron W. Mulivor, Sara Gardenghi, Stefano Rivella, Asya V. Grinberg, R. Scott Pearsall, Ravindra Kumar	117
6	Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis breakdown → 2014 ·Nature Medicine ·Rajasekhar N.V.S. Suragani, Samuel M. Cadena, Sharon M Cawley, Dianne Sako, Dianne Mitchell, Robert Li, Monique V. Davies, Mark J. Alexander, Matthew Devine, Kenneth S. Loveday, Kathryn Underwood, Asya V. Grinberg, John D. Quisel, Rajesh Chopra, R. Scott Pearsall, Jasbir Seehra, Ravindra Kumar	346
7	Activin receptor antagonists for cancer-related anemia and bone disease 2012 ·Expert Opinion on Investigational Drugs ·Scott Z. Fields, (unknown), (unknown), H. Raftopoulos, Mark J. Alexander, Matthew L. Sherman, Abderrahmane Laadem, Victoria Sung, Evangelos Terpos	53
8	Effects of prenatal malnutrition on GABAA receptor α1, α3 and β2 mRNA levels 2003 ·Neuroreport ·(unknown), Mark J. Alexander, Janina R. Galler, David H. Farb, Shelley J. Russek	25
9	Colocalization of Neurotensin Messenger Ribonucleic Acid (mRNA) and Progesterone Receptor mRNA in Rat Arcuate Neurons under Estrogen-Stimulated Conditions¹ 1999 ·Endocrinology ·Mark J. Alexander	13
10	Widespread expression in adult rat forebrain of mRNA encoding high-affinity neurotensin receptor 1998 ·The Journal of Comparative Neurology ·Mark J. Alexander, Susan E. Leeman	92
11	Widespread expression in adult rat forebrain of mRNA encoding high‐affinity neurotensin receptor 1998 ·The Journal of Comparative Neurology ·Mark J. Alexander, Susan E. Leeman	7
12	Neurotensin and Neuroendocrine Regulation 1997 ·Frontiers in Neuroendocrinology ·William Rostène, Mark J. Alexander	124
13	Estrogen‐inducible neurotensin immunoreactivity in the preoptic area of the female rat 1994 ·The Journal of Comparative Neurology ·Mark J. Alexander, Susan E. Leeman	34
14	Neurotensin Gene Expression in the Rat Preoptic Area 1992 ·Annals of the New York Academy of Sciences ·Mark J. Alexander, Susan E. Leeman	12
15	Evidence that Neurotensin Participates in the Central Regulation of the Preovulatory Surge of Luteinizing Hormone in the Rat* 1989 ·Endocrinology ·Mark J. Alexander, Paul Mahoney, Craig F. Ferris, Robert E. Carraway, Susan E. Leeman	40
16	Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide 1988 ·Brain Research ·Mark J. Alexander, Donald K. Clifton, Alvin M. Matsumoto, Robert A. Steiner	1
17	Vasoactive Intestinal Polypeptide Effects a Central Inhibition of Pulsatile Luteinizing Hormone Secretion in Ovariectomized Rats* 1985 ·Endocrinology ·Mark J. Alexander, Donald K. Clifton, Robert A. Steiner	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact